| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | May 20, 2025 | Burkhart Erin GVP Chief Accounting Officer | Sell | Biomarin Pharmaceutical Inc | BMRN | $59.31 | $105,928 | -11.19% |
| Mar 19, 2025 | Mar 20, 2025 | Burkhart Erin GVP Chief Accounting Officer | Sell | Biomarin Pharmaceutical Inc | BMRN | $71.52 | $92,618 | -7.10% |
| Feb 24, 2025 | Feb 26, 2025 | Burkhart Erin GVP Chief Accounting Officer | Sell | Biomarin Pharmaceutical Inc | BMRN | $68.38 | $91,903 | -9.30% |
| Aug 13, 2024 | Aug 15, 2024 | Burkhart Erin GVP Chief Accounting Officer | Sell | Biomarin Pharmaceutical Inc | BMRN | $90 | $64,260 | -4.71% |
| Apr 10, 2024 | Apr 12, 2024 | Burkhart Erin GVP Chief Accounting Officer | Sell | Biomarin Pharmaceutical Inc | BMRN | $90 | $205,740 | -12.40% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.